Skip to content

Open for responses

U.S. FOOD & DRUG ADMINISTRATION (FDA) OFFICE OF INSPECTIONS AND INVESTIGATIONS (OII) BIOMANUFACTURING PRINCIPLES AND PROCESSES TRAINING SERIES

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Notice type
Sources Sought
Solicitation #
OII-2027-133938
NAICS
611430
Posted
November 17, 2026
Response due
December 1, 2027
Place of performance
Silver Spring, MD

Description

STATEMENT OF WORK FOOD AND DRUG ADMINISTRATION (FDA) OFFICE OF INSPECTIONS AND INVESTIGATIONS (OII) BIOMANUFACTURING PRINCIPLES AND PROCESSES TRAINING SERIES Contents Background Objective Scope Tasks Deliverables Contract Type Place of Performance Period of Performance Assumptions and Constraints Government Furnished Equipment/Information/Property Authorized Contacts Travel, Materials, and Incidental Services Holidays and Government Closures Government Contacts 508 Standard Requirements Security Requirements Background The Food and Drug Administration (FDA) is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation's food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable, and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health. The U.S. Food and Drug Administration (FDA) Office of Inspections and Investigations (OII) coordinates domestic and foreign inspectional, quality and investigational activities across the field and at headquarters. In addition, OII works closely with other FDA Offices on compliance and enforcement activities and to implement policies related to the Pharmaceutical program. The Office of Training, Education, and Development’s (OTED) Division of Inspections and Investigations trains field and headquarter investigators and analysts to conduct inspections of biopharmaceutical and pharmaceutical manufacturing processes and practices for compliance with good manufacturing practices (GMP) regulations. The trainees for the Biomanufacturing Principles and Processes Curriculum will typically have five (5) or more years of agency experience and hold a Bachelor of Science degree. Some will have a background in chemistry, biochemistry, microbiology or engineering. OTED has created a comprehensive curriculum series to provide investigators with additional biological therapeutic drug training in the following areas: Product development and manufacturing processes Facility and equipment design Technology transfer Manufacturing processes Analytical Testing Methods Objective OTED requires one individual contractor to deliver an enhanced four-course training curriculum including course material, modules, webinars, and hands-on training, as necessary, to FDA investigators. This will allow FDA inspectors to experience the production of biological therapeutic drug products thereby enabling them to better understand biomanufacturing principles and processes to include facility equipment design, product manufacturing processes, analytical testing methods, and emerging technologies in biomanufacturing. The training will provide investigators with the skills and knowledge to determine areas of highest risk during inspections of biopharmaceutical manufacturing facilities. Scope OTED seeks a contractor/institution that does not create/produce products that are or will be regulated by the FDA and/or marketed or introduced to the market and thus regulated by FDA. The contractor shall deliver curricula via distance learning, followed by classroom instruction, coupled with practical experience in the contractor's facility. Course delivery shall consist of asynchronous web-based learning via the BTEC Shorts platform, synchronous web-based webinars, synchronous classroom training, and hands-on/laboratory training. The contractor shall develop and maintain comprehensive instructor and participant guides to accompany the delivery of the synchronous classroom and laboratory training with respect to the manufacture of biological therapeutic drugs. OII employees will have access to the web from their desktop for asynchronous learning components. OII employees will travel to the contractor's facility for the on-site portion of the training. Students must complete all four (4) courses within 12 months. Each course allows for a maximum enrollment of 25 students, takes place over a five-week period, and requires 32 contact hours. A total of eight contact hours shall be provided via online instruction for applicable courses. The remaining 24 hours of instructional time take place over three days onsite at the contractor's facility in the fifth and final week of the course. The entire curriculum must be available for student enrollment by the end of the base year. The first course must be finalized and ready for student enrollment within 6 months from award of contract. The first cohort must complete at least half of the curriculum before the end of the base year of the contract. By the end of the fourth option year, six (6) separate cohorts will have completed the entire curriculum. Tasks The contractor shall perform each of the following tasks within the parameters outlined in this section. The scope of work section details the overall requirements for delivering the biomanufacturing principles and processes curriculum and developing the accompanying instructor and participant guides for that curriculum. Task One: Administrative Throughout this Order, the Contractor shall work with the FDA's Contracting Officer Representative (COR), various FDA staffers and the Contracting Officer (CO), to provide technical and/or administrative assistance, review, and support services for the FDA to ensure that the tasks are performed efficiently, accurately, on time, and in compliance with the requirements of this SOW. The Contractor shall coordinate, as necessary, with the technical POC and the COR to ensure that the tasks are managed consistently in accordance with overall Order requirements. The Contractor shall ensure timely and accurate submission of invoices that shall track, at a minimum, the hours utilized during each in…

Source: SAM.gov, as posted. Verify the current solicitation before responding.

Pursue this opportunity with Mindy

See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.

View the original notice on SAM.gov ↗

Open opportunities in NAICS 611430